Raphas Co., Ltd. (214260) — research page
KR · kr-cm-kg/KOSDAQ/214260 · as of 2026-11-06
Identity and listing
The issuer is Raphas Co., Ltd., listed on KOSDAQ under ticker 214260 and ISIN KR7214260002; its LEI is not on the record. Its security type is Corporate and its segment is not on the record. Its sector is 기타 화학제품 제조업 and its jurisdiction is South Korea, a DART filer with a corporate registration number. Its status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Raphas Co., Ltd. | source · 2026-11-06 |
| exchange | KOSDAQ | source · 2026-11-06 |
| ticker | 214260 | source · 2026-11-06 |
| ISIN | KR7214260002 | source · 2026-11-08 |
| LEI | not on the record | |
| security type | Corporate | source · 2026-11-06 |
| segment | not on the record | |
| sector | 기타 화학제품 제조업 | source · 2026-11-06 |
| jurisdiction | South Korea (DART filer with a corporate registration number) | source · 2026-11-06 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 26 filings in the twelve months to 2026-11-06, across 17 filing days. The median gap between filing days is 8.0 days. The latest filing is dated 2026-08-14 and is of type results, 84 days before the record date. The KOSDAQ median cadence gap is 8.0 days, the median filings are 33, and the median latency is 16.0 days across 1819 issuers. The 기타 화학제품 제조업 sector median cadence gap is 8.2 days, the median filings are 34, and the median latency is 14.0 days across 103 issuers.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 26 | 8 | 84 |
| exchange median: KOSDAQ (1819 issuers) | 33 | 8 | 16 |
| sector median: 기타 화학제품 제조업 (103 issuers) | 34 | 8.2 | 14 |
| date | type | category | filing |
|---|---|---|---|
| 2026-08-14 | results | 반기보고서 (2026.06) | |
| 2026-06-02 | directors_dealings | 임원ㆍ주요주주특정증권등소유상황보고서 | |
| 2026-05-28 | corporate_news | [기재정정]투자판단관련주요경영사항(임상시험계획승인신청) (알레르기비염 면역치료제 DF19001의 임상 2b/3상 임상시험계획(IND) 승인 신청) | |
| 2026-05-22 | corporate_news | 투자판단관련주요경영사항(임상시험계획승인신청) (알레르기비염 면역치료제 DF19001의 임상 2b/3상 임상시험계획(IND) 승인 신청) | |
| 2026-05-15 | results | 분기보고서 (2026.03) |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is 이촌회계법인; its location is not on the record. The record does not carry auditor changes for this register.
Events and halts
The record does not carry listing, delisting, name change, domicile change or segment move lines for this register, as no lifecycle type map exists yet. The halt flag is not set: the issuer is listed, not halted.
Orderability
The outcome cannot be determined for this issuer, because the chapter's orderability section carries no client categories. The rule version is acm-68000/kr/suitability-and-appropriateness-fscma-articles-46-and-46-2/r1, and the chapter is as of 2026-11-04.
rule acm-68000/kr/suitability-and-appropriateness-fscma-articles-46-and-46-2/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The field has not been read, so the number of research houses named on the issuer's investor-relations page is not on the record.
Open research
The field has not been read, so the count of openly published research notes is not on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed. Years 2021 through 2026 are sealed in the store but not served as of this date, and the as-of door answers not_sealed. The live record began on 2026-09-12.
Sources
8 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://kind.krx.co.kr/corpgeneral/corpList.do?method=download&searchType=13 (identity.exchange)
- 10.2
- https://data.krx.co.kr/comm/bldAttendant/getJsonData.cmd (identity.isin)
- 10.3
- https://opendart.fss.or.kr/api/company.json?corp_code=01058101 (identity.jurisdiction)
- 10.4
- https://mcp.kr-cm-kg.ai/events/KOSDAQ/214260 (the disclosure lines)
- 10.5
- https://kind.krx.co.kr/investwarn/tradinghaltissue.do?method=searchTradingHaltIssueMain (the halt flag)
- 10.6
- https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260320001360 (the auditor)
- 10.7
- https://mcp.kr-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.8
- https://mcp.kr-cm-kg.ai/record/KOSDAQ/214260 (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"KR7214260002"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:7a852483141a1b0c.